Condition Deep-Dives 10 min read·Updated 22 July 2026 Clinician-reviewed

Renal Vein Thrombosis

A UK Consultant Nephrologist on renal vein thrombosis — a frequently missed complication of nephrotic syndrome (especially membranous nephropathy), and an important consideration in trauma, malignancy and antiphospholipid syndrome. Prompt recognition prevents pulmonary embolism and salvages kidney function.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

RVT is most commonly seen in adults with nephrotic syndrome — particularly membranous nephropathy with albumin < 25–28 g/L. Diagnose with CT venography or MRV. Anticoagulate (LMWH then warfarin or DOAC) for at least the duration of nephrosis + 3–6 months. Treat the underlying disease.

Key recommendation: Always consider in nephrotic syndrome, especially membranous.

Quick answer

✓ Best choices

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

✓ Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Key takeaway

RVT is most commonly seen in adults with nephrotic syndrome — particularly membranous nephropathy with albumin < 25–28 g/L. Diagnose with CT venography or MRV. Anticoagulate (LMWH then warfarin or DOAC) for at least the duration of nephrosis + 3–6 months. Treat the underlying disease.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

Renal Vein Thrombosis

Causes & risk factors

Adults

1. NEPHROTIC SYNDROME (commonest):

  • Membranous nephropathy — highest risk (10–35% of cases)
  • FSGS, minimal change, lupus nephritis class V
  • Serum albumin < 25–28 g/L is the strongest predictor
  • Proteinuria > 8 g/day, prior VTE, immobility, malignancy compound risk
  • Mechanism: urinary loss of antithrombin, protein S, plasminogen; raised fibrinogen, factor V, factor VIII

2. Renal Cell Carcinoma

  • Tumour thrombus extends from vein into IVC and right atrium
  • Influences surgical approach (radical nephrectomy + thrombectomy)

3. Trauma / Surgery / Extrinsic Compression

  • Direct vein injury, retroperitoneal haematoma, IVC catheter
  • Pancreatic / retroperitoneal malignancy
  • 'Nutcracker' syndrome (left RV compressed between aorta and SMA)

4. Thrombophilia

  • Antiphospholipid syndrome
  • Hereditary thrombophilia (rarely sole cause)
  • Oestrogen-containing OCP, pregnancy, malignancy
  1. SEVERE DEHYDRATION / SHOCK

Neonates

  • Septic, dehydrated, perinatal asphyxia
  • Often unilateral
  • Presents as flank mass + haematuria + thrombocytopenia
  • High morbidity; specialist neonatal nephrology care

Diagnosis

Clinical

  • Acute RVT: flank pain, gross haematuria, AKI, fever
  • Chronic RVT: gradual onset, worsening proteinuria, mild AKI, often asymptomatic
  • Bilateral disease can cause oliguric AKI
  • PE may be presenting feature

Bloods

  • Rising creatinine
  • LDH ↑ (from ischaemic injury)
  • Worsening proteinuria
  • Check D-dimer (raised), full clotting screen, antiphospholipid antibodies, thrombophilia panel (interpret cautiously in nephrosis — protein S/AT often falsely low from urinary loss)
  • Tumour markers if RCC suspected

Imaging

  • CT VENOGRAPHY — first-line; high sensitivity/specificity; identifies tumour thrombus, extension into IVC
  • MR VENOGRAPHY — useful when contrast contraindicated; excellent soft tissue detail
  • DOPPLER USS — non-invasive, no contrast, but operator-dependent; useful in pregnancy/children
  • Renal venography (catheter) — historical gold standard, rarely needed now

Incidental Finding

  • Many cases found on staging CT for malignancy or follow-up for known nephrotic syndrome
  • Always check for PE on the same study

Kidney Biopsy

  • Indicated to diagnose underlying nephrotic syndrome (typically membranous)
  • Defer if active anticoagulation needed urgently
  • Coordinate with histopathology for tumour vs thrombosis differential

Treatment

Acute Phase

  • LMWH (e.g. enoxaparin 1 mg/kg bd, dose-adjusted for renal function) — start immediately on diagnosis
  • Avoid IV unfractionated heparin unless eGFR is very low or rapid reversal might be needed
  • Treat AKI / fluid overload supportively
  • Catheter-directed thrombolysis or thrombectomy: reserved for bilateral RVT with AKI, single functioning kidney, or extension into IVC threatening haemodynamics — specialist vascular/interventional centres only
  • IVC filter: consider for proven PE with contraindication to anticoagulation, or recurrent PE on anticoagulation

Maintenance Anticoagulation

  • Warfarin (target INR 2.0–3.0) — best evidence, especially in severe nephrotic syndrome
  • DOACs (apixaban or rivaroxaban) — increasingly used in stable patients with serum albumin > 25 g/L and eGFR > 30; lack of large RCT data in nephrotic RVT; some pharmacokinetic concern with profound hypoalbuminaemia
  • LMWH long-term in pregnancy, malignancy or where oral agents not suitable

Duration

  • Nephrotic syndrome RVT: minimum 6 months; continue until nephrotic syndrome resolved + 3–6 months
  • Persistent nephrotic syndrome: lifelong
  • Provoked (trauma/surgery): 3–6 months
  • Unprovoked or APS: long-term / lifelong

Treat The Underlying Disease

  • Membranous: PLA2R antibody testing; specific immunosuppression (rituximab is now first-line in moderate-to-high risk under NICE/UK pathways)
  • Other primary glomerulonephritis treated per histology
  • RCC: urology referral for surgical thrombectomy and oncology workup

Primary Prophylaxis In Nephrotic Syndrome

  • Consider prophylactic anticoagulation in membranous nephropathy with serum albumin < 20 g/L (some centres < 25)
  • Use the GlasGo / GlomCon nephrotic anticoagulation calculator to balance bleed vs clot risk
  • Aspirin alternative is sometimes used but weaker evidence

Follow-up

  • Repeat imaging at 3–6 months — many thrombi recanalise
  • Monitor proteinuria, serum albumin, eGFR, BP
  • Document recovery of kidney function
  • Joint nephrology + haematology care for thrombophilia and anticoagulation duration decisions
Membranous Nephropathy
Related reading: Membranous Nephropathy.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Cook from scratch when you can
  • Read sodium labels (≤ 0.3 g per 100 g is low)
  • Take any concerns to your GP or renal team early

Clinical guidance

TL;DR summary

RVT is most commonly seen in adults with nephrotic syndrome — particularly membranous nephropathy with albumin < 25–28 g/L. Diagnose with CT venography or MRV. Anticoagulate (LMWH then warfarin or DOAC) for at least the duration of nephrosis + 3–6 months. Treat the underlying disease.

Key takeaways
  • Always consider in nephrotic syndrome, especially membranous.
  • Acute: flank pain, haematuria, AKI. Chronic: often silent.
  • CT venography or MRV is diagnostic.
  • Anticoagulate for nephrosis duration + 3–6 months minimum.
  • Warfarin is best-evidenced; DOACs used cautiously.
Kidney Diet & Nutrition Considerations

Diet is one of the most powerful tools you have to look after your kidneys. UK renal guidance points to a Mediterranean-style, reduced-salt pattern: plenty of vegetables, lower-potassium fruit, whole grains, sensible protein, beans and pulses in moderation, oily fish and olive oil. Personal targets — for potassium, phosphate, protein and fluid — should be set by your renal team based on your bloods.

Foods to prioritise

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

Who develops renal vein thrombosis?

Three classic groups: (1) adults with nephrotic syndrome — particularly membranous nephropathy, where serum albumin < 25–28 g/L and proteinuria > 8 g/day mark the highest risk; (2) patients with renal cell carcinoma (tumour thrombus extending into the renal vein/IVC); (3) trauma, abdominal surgery, IVC compression, antiphospholipid syndrome and severe dehydration. Neonatal RVT is a separate entity, usually in dehydrated or septic newborns.

How does it present?

Acute RVT can cause flank pain, haematuria, AKI, low-grade fever and a rising LDH. Chronic / progressive RVT is often silent — the thrombus develops slowly with collaterals — and is found on imaging done for another reason or because of worsening proteinuria. Pulmonary embolism may be the first sign in nephrotic patients. CT venography or MR venography is diagnostic; doppler USS has good sensitivity but is operator-dependent.

How long do patients need anticoagulation?

For RVT secondary to active nephrotic syndrome, anticoagulate for as long as the patient remains nephrotic and for ≥ 3–6 months after remission. Patients with persistent nephrotic syndrome may need lifelong anticoagulation. Non-nephrotic provoked RVT (trauma, surgery): 3–6 months. Unprovoked or with persistent risk factor (malignancy, APS): long-term.

Warfarin or DOAC?

Warfarin (target INR 2.0–3.0) is the most evidence-based agent for nephrotic-related RVT. DOACs (apixaban, rivaroxaban) are increasingly used in stable patients with eGFR > 30 and serum albumin > 25 g/L, but evidence is limited and severe hypoalbuminaemia may alter DOAC pharmacokinetics unpredictably. Heparin (LMWH then warfarin/DOAC) is first-line in acute RVT until anticoagulation is established.

What foods are good for kidney health?

A Mediterranean-style, mostly plant-based, reduced-salt diet is the most consistent evidence-based pattern for kidney health. Build meals around vegetables, lower-potassium fruit, whole grains, fish, eggs or tofu, beans and pulses in moderation, and olive oil.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK guidance

Aligned with British Society for Haematology VTE guidance, NICE NG158 venous thromboembolic disease, KDIGO 2021 glomerular disease guidelines and UK Kidney Association nephrotic syndrome pathways.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Joint nephrology + haematology care

Practical guidance on anticoagulation choice, duration and primary prophylaxis decisions in nephrotic syndrome.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal
Subscribe & Save — £20.39/monthCheck your current multivitamin

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.

← Back to all guides